Diego Montagner

Maynooth, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

68Ga radiolabeling strategies in Pt(IV)-deferoxamine scaffolds for potential theranostic application.

68Ga radiolabeling strategies in Pt(IV)-deferoxamine scaffolds for potential theranostic application.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: December 08, 2025

Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity against Renal Cell Carcinoma When Compared to Conventional Platinum Chemotherapy.

Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity against Renal Cell Carcinoma When Compared to Conventional Platinum Chemotherapy.

Journal: Journal of medicinal chemistry

Published: November 10, 2025

Recent Advances on Pt-Based Compounds for Theranostic Applications.

Recent Advances on Pt-Based Compounds for Theranostic Applications.

Journal: Molecules (Basel, Switzerland)

Published: July 02, 2024

2D and 3D anticancer properties of C2-functionalised glucosamine-Pt (IV) prodrugs based on cisplatin scaffold.

2D and 3D anticancer properties of C2-functionalised glucosamine-Pt (IV) prodrugs based on cisplatin scaffold.

Journal: Frontiers in chemistry

Published: February 19, 2024

Novel design of dual-action Pt(IV) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib.

Novel design of dual-action Pt(IV) anticancer pro-drugs based on cisplatin and derivatives of the tyrosine kinase inhibitors imatinib and nilotinib.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: September 25, 2023

Novel Biotinylated Cu(II)-Phenanthroline Complexes: 2D and 3D Cytotoxic Activity and Mechanistic Insight.

Novel Biotinylated Cu(II)-Phenanthroline Complexes: 2D and 3D Cytotoxic Activity and Mechanistic Insight.

Journal: Molecules (Basel, Switzerland)

Published: April 13, 2023

Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma.

Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma.

Journal: International journal of molecular sciences

Published: February 27, 2023

Graphene Oxide Nanoplatforms to Enhance Cisplatin-Based Drug Delivery in Anticancer Therapy.

Graphene Oxide Nanoplatforms to Enhance Cisplatin-Based Drug Delivery in Anticancer Therapy.

Journal: Nanomaterials (Basel, Switzerland)

Published: June 21, 2022

Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma.

Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma.

Journal: Frontiers in chemistry

Published: October 15, 2021

Antimicrobials offered from nature: Peroxidase-catalyzed systems and their mimics.

Antimicrobials offered from nature: Peroxidase-catalyzed systems and their mimics.

Journal: Biochemical pharmacology

Published: August 10, 2020

Pt(IV) pro-drugs with an axial HDAC inhibitor demonstrate multimodal mechanisms involving DNA damage and apoptosis independent of cisplatin resistance in A2780/A2780cis cells.

Pt(IV) pro-drugs with an axial HDAC inhibitor demonstrate multimodal mechanisms involving DNA damage and apoptosis independent of cisplatin resistance in A2780/A2780cis cells.

Journal: Journal of inorganic biochemistry

Published: February 21, 2020

Anticancer activity, DNA binding and cell mechanistic studies of estrogen-functionalised Cu(II) complexes.

Anticancer activity, DNA binding and cell mechanistic studies of estrogen-functionalised Cu(II) complexes.

Journal: Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry

Published: August 08, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026